Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences
Data updated
Research Footprint
Laura Michele Hack appears in 4 tracked papers (2023–2026), most studied alongside Ketamine, LSD and Psilocybin, across Depressive Disorders, Anxiety Disorders and Neuroimaging & Brain Measures.
Most-cited paper: Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients (91 citations).
Frequent co-authors: Xue Zhang, Luke Williams and Boris Heifets.
Background & Research
Laura Michele Hack, MD, PhD, is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University and the Veterans Affairs Palo Alto Health Care System. Her research focuses on identifying bioclinical subtypes of depression and testing mechanistically guided treatments, including ketamine, MDMA, psilocybin, and neuromodulation. Clinically, she works with treatment-resistant depression and trauma-related disorders.
Key Impact
She is a Stanford psychiatrist-researcher known for mechanistic clinical trials and translational work on ketamine, MDMA, and psilocybin-related brain and affective circuitry.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →